Healthequity Inc (NASDAQ:HQY)’s stock price rose 2.2% during mid-day trading on Thursday . The stock traded as high as $68.03 and last traded at $68.96, approximately 38,918 shares were traded during trading. A decline of 96% from the average daily volume of 974,207 shares. The stock had previously closed at $67.46.
HQY has been the topic of several analyst reports. KeyCorp set a $37.00 target price on SeaWorld Entertainment and gave the company a “buy” rating in a research report on Tuesday, March 19th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Evolus in a research report on Tuesday, March 19th. ValuEngine cut Acceleron Pharma from a “strong-buy” rating to a “buy” rating in a research report on Thursday, April 18th. Raymond James lifted their target price on Whitecap Resources from C$8.50 to C$8.75 and gave the company a “strong-buy” rating in a research report on Monday, June 10th. Finally, Zacks Investment Research cut HENGAN INTL GRP/ADR from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, May 21st. Four investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Healthequity has an average rating of “Buy” and an average target price of $86.25.
The stock has a 50-day simple moving average of $66.73. The company has a current ratio of 15.60, a quick ratio of 15.59 and a debt-to-equity ratio of 0.07. The firm has a market capitalization of $4.29 billion, a price-to-earnings ratio of 72.26, a PEG ratio of 3.22 and a beta of 1.46.
In other Healthequity news, VP Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction on Monday, May 20th. The stock was sold at an average price of $68.17, for a total value of $272,680.00. Following the transaction, the vice president now owns 64,100 shares of the company’s stock, valued at $4,369,697. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In the last three months, insiders sold 12,000 shares of company stock worth $824,560. Insiders own 3.70% of the company’s stock.
Hedge funds have recently bought and sold shares of the business. Deutsche Bank AG boosted its position in Healthequity by 29.7% in the fourth quarter. Deutsche Bank AG now owns 383,388 shares of the company’s stock worth $22,867,000 after purchasing an additional 87,736 shares during the last quarter. Neuburgh Advisers LLC boosted its position in Healthequity by 5.6% in the first quarter. Neuburgh Advisers LLC now owns 31,600 shares of the company’s stock worth $2,338,000 after purchasing an additional 1,664 shares during the last quarter. Bfsg LLC purchased a new position in Healthequity in the first quarter worth $460,000. Ashford Capital Management Inc. lifted its position in shares of Healthequity by 2.3% during the 4th quarter. Ashford Capital Management Inc. now owns 146,089 shares of the company’s stock valued at $8,714,000 after buying an additional 3,300 shares during the last quarter. Finally, Sawtooth Solutions LLC purchased a new position in shares of Healthequity during the 1st quarter valued at $325,000. 96.03% of the stock is currently owned by institutional investors and hedge funds.
Healthequity Company Profile (NASDAQ:HQY)
HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Featured Article: What is range trading?
Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.